FX006 10 mg
Sponsors
Pacira Pharmaceuticals, Inc
Conditions
Osteoarthritis of the Knee
Phase 2
Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee
CompletedNCT01487200
Start: 2012-07-31End: 2012-11-30Updated: 2024-01-24
Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee
CompletedNCT02003365
Start: 2013-11-30End: 2014-04-30Updated: 2024-01-24